Evidence map›Paper›PMID 28053639›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2016

Evaluation of Antibacterial, Antineoplastic, and Immunomodulatory Activity of

Lidiane Vasconcelos do Nascimento Carvalho, Marina Ferraz Cordeiro, Thiago Ubiratan Lins E Lins, Maria Clara Pinheiro Duarte Sampaio, Gabriela Souto Vieira de Mello, Valécia de Cassia Mendonça da Costa, Leila Larisa Medeiros Marques, Traudi Klein, João Carlos Palazzo de Mello, Isabella Macário Ferro Cavalcanti and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.7field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Biosynthesis of Silver Nanoparticles fromPharmaceuticals (Basel, Switzerland) · 2025
    Article
  3. Article
  4. Article
  5. Guarana (Paullinia cupana) as a potential tool for mesenchymal stromal cells priming in regenerative medicine.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica · 2024
    Article
  6. Organic Extract ofEvidence-based complementary and alternative medicine : eCAM · 2018
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Lidiane Vasconcelos do Nascimento CarvalhoLaboratory of Immunomodulation and New Therapeutical Approaches, Research Centre for Therapeutic Innovation Suely Galdino (NUPIT-SG), Federal University of Pernambuco, Recife, PE, Brazil.
Marina Ferraz CordeiroLaboratory of Immunomodulation and New Therapeutical Approaches, Research Centre for Therapeutic Innovation Suely Galdino (NUPIT-SG), Federal University of Pernambuco, Recife, PE, Brazil.
Thiago Ubiratan Lins E LinsLaboratory of Immunomodulation and New Therapeutical Approaches, Research Centre for Therapeutic Innovation Suely Galdino (NUPIT-SG), Federal University of Pernambuco, Recife, PE, Brazil.
Maria Clara Pinheiro Duarte SampaioLaboratory of Immunomodulation and New Therapeutical Approaches, Research Centre for Therapeutic Innovation Suely Galdino (NUPIT-SG), Federal University of Pernambuco, Recife, PE, Brazil.
Gabriela Souto Vieira de MelloLaboratory of Immunomodulation and New Therapeutical Approaches, Research Centre for Therapeutic Innovation Suely Galdino (NUPIT-SG), Federal University of Pernambuco, Recife, PE, Brazil.
Valécia de Cassia Mendonça da CostaLaboratory of Immunomodulation and New Therapeutical Approaches, Research Centre for Therapeutic Innovation Suely Galdino (NUPIT-SG), Federal University of Pernambuco, Recife, PE, Brazil.
Leila Larisa Medeiros MarquesPharmacy Department, Maringa State University, Maringa, PR, Brazil.
Traudi KleinPharmacy Department, Ponta Grossa State University, Ponta Grossa, PR, Brazil.
João Carlos Palazzo de MelloPharmacy Department, Maringa State University, Maringa, PR, Brazil.
Isabella Macário Ferro CavalcantiMicrobiology and Immunology Laboratory of Academic Center of Vitória, Federal University of Pernambuco, Recife, PE, Brazil.
Ivan da Rocha PittaLaboratory of Immunomodulation and New Therapeutical Approaches, Research Centre for Therapeutic Innovation Suely Galdino (NUPIT-SG), Federal University of Pernambuco, Recife, PE, Brazil.
Maira Galdino da Rocha PittaLaboratory of Immunomodulation and New Therapeutical Approaches, Research Centre for Therapeutic Innovation Suely Galdino (NUPIT-SG), Federal University of Pernambuco, Recife, PE, Brazil.ORCID 0000-0001-5881-0338
Moacyr Jesus Barreto de Melo RêgoLaboratory of Immunomodulation and New Therapeutical Approaches, Research Centre for Therapeutic Innovation Suely Galdino (NUPIT-SG), Federal University of Pernambuco, Recife, PE, Brazil.ORCID 0000-0002-1883-6012
Universidade Federal de Pernambuco · BRUniversidade Estadual de Maringá · BRUniversidade Estadual de Ponta Grossa · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID28053639
PMCPMC5174172
OpenAlexW2560327779

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.